本次重组类型为购买资产，收购方式为非公开发行股份，交易标的为威宇医疗100.0%股权，本次交易含配套融资。上市公司拟发行股份购买威宇医疗100%股权，同时拟向盛世达、宁湧超及和亚基金非公开发行股份募集配套资金，募集配套资金总额预计不超过4.40亿元，且不超过本次发行股份购买资产交易价格的100%。经交易各方协商一致，本次重组标的资产交易作价20,800.00万元。本次交易构成关联交易、重大资产重组，不构成重组上市。
荣丰控股：发行股份购买资产并募集配套资金暨关联交易预案（修订稿）
Rongfeng Holdings: Plan for Issuing Shares to Purchase Assets and Raise Supporting Funds and Related Transactions (Revised Draft)
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Hot News
Updated